PHOENIX-OITB Launches 2nd Round of its Open Call Offering Funded Services in Nanopharmaceutical Development

Applications are open from 11 March 2024 – 3 May 2024 for the PHOENIX-OITB Open Call Round 2! 

PHOENIX-OITB’s mission is to offer a Single-Entry-Point for a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects from characterization, testing, verification up to scale-up, GMP compliant manufacturing and regulatory guidance in the field of nanopharmaceutical development, framing the OITB clearly within the nanomedicine field.

The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. Under the scope of the Open Call, we offer the following service categories:

• Physico-Chemical Characterization,
• In vitro Characterisation,
• In vivo Characterisation and
• Manufacturing

How to apply:

Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.

The Evaluation Committee will evaluate each proposal in three main criteria:

• Excellence
• Implementation
• Impact

The applicants will be informed about the decision made by the Evaluation Committee by the end of 03.05.2024 via email. A Stage 2 detailed application must then be submitted by 28.06.2024. Awarded projects must be completed by the end of the PHOENIX project (2025).

For more information and all application documents, visit our website.